Foremost At Sharon Llc
FOREMOST AT SHARON LLC in SHARON, MA — inspection on June 12, 2024.
Found 2 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
Review of a Norton Plus Pressure Ulcer Scale, dated 4/23/24, indicated Resident #23 had a score of 6.0 (score of less than 10 is very high risk) and was at Very High Risk for developing pressure ulcers.
Review of the most recent MDS assessment, dated 4/25/24, indicated Section M-Skin Conditions section M0150 (risk of pressure ulcers) question: Is this resident at risk for developing pressure ulcers? The answer was documented No.
During an interview on 6/10/24 at 8:33 A.M., the MDS Coordinator reviewed section M of Resident #23's 4/25/24 MDS and the Norton Pressure Ulcer Risk assessment, dated 4/23/24.
She said the Resident scored a 6.0 which indicated a high risk for developing pressure ulcers.
She said she clicked No by mistake on the 4/25/24 MDS assessment for pressure ulcer risk and needed to do a modification to the MDS to accurately reflect the Resident's risk.
225134
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 225134 B.
Wing 06/12/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Foremost at Sharon LLC 259 Norwood Street Sharon, MA 02067
Review of the Minimum Data Set (MDS) assessment, dated 5/25/24, indicated Resident #34 had a Brief Interview for Mental Status (BIMS) score of 6 out of 15, which is indicative of severe cognitive impairment.
Further review of the MDS also indicated Resident #34 had received anticoagulant medication.
Review of Resident #34's current Physician's Orders indicated but was not limited to:
-Lovenox injection solution (an anticoagulant) prefilled syringe 40 milligrams (mg)/0.4 milliliters.
Inject 1 vial subcutaneously one time a day for blood thinner; start date 5/22/24.
-Clopidogrel (antiplatelet) 75 mg.
Give 1 tablet by mouth one time a day for blood thinner; start date 5/22/24.
-Aspirin 81 mg.
Give 81 mg by mouth one time a day for prevention; start date 5/22/24.
Review of Resident #34's May 2024 and June 2024 Medication Administration Record (MAR) indicated he/she was administered Lovenox, Clopidogrel, and Aspirin as ordered.
Review of Resident #34's Physician's History and Physical Note, dated 5/22/24, indicated but was not limited to:
225134
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 225134 B.
Wing 06/12/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Foremost at Sharon LLC 259 Norwood Street Sharon, MA 02067